Great Diamond Partners LLC Has $2.61 Million Stake in Unum Group (NYSE:UNM)

Great Diamond Partners LLC lessened its position in Unum Group (NYSE:UNM) by 0.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,684 shares of the financial services provider’s stock after selling 182 shares during the period. Great Diamond Partners LLC’s holdings in Unum Group were worth $2,606,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of UNM. Capital Performance Advisors LLP bought a new stake in shares of Unum Group during the third quarter worth about $31,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Unum Group during the 3rd quarter worth approximately $37,000. V Square Quantitative Management LLC grew its holdings in Unum Group by 38.2% during the 3rd quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock worth $42,000 after acquiring an additional 194 shares during the last quarter. Quarry LP increased its position in Unum Group by 4,794.7% in the 3rd quarter. Quarry LP now owns 930 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 911 shares during the period. Finally, Versant Capital Management Inc raised its stake in shares of Unum Group by 26.4% during the fourth quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider’s stock valued at $56,000 after acquiring an additional 160 shares during the last quarter. 86.57% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Unum Group

In other news, CAO Walter Lynn Rice, Jr. sold 1,500 shares of Unum Group stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $69.56, for a total transaction of $104,340.00. Following the completion of the transaction, the chief accounting officer now directly owns 8,361 shares in the company, valued at $581,591.16. This trade represents a 15.21 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the company’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $76.92, for a total transaction of $769,200.00. Following the completion of the sale, the executive vice president now owns 54,827 shares in the company, valued at $4,217,292.84. This represents a 15.43 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 102,914 shares of company stock valued at $7,677,945. Company insiders own 0.93% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on UNM shares. Barclays boosted their price objective on shares of Unum Group from $76.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, January 6th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $79.00 price target (up previously from $74.00) on shares of Unum Group in a research note on Tuesday, January 7th. Truist Financial lifted their price objective on Unum Group from $70.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. Wells Fargo & Company increased their target price on shares of Unum Group from $74.00 to $81.00 and gave the company an “overweight” rating in a research report on Tuesday, January 14th. Finally, Morgan Stanley boosted their price target on shares of Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 30th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $79.00.

Unum Group Stock Down 1.0 %

Shares of NYSE UNM opened at $76.25 on Friday. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32. The firm has a market cap of $13.92 billion, a PE ratio of 8.25, a P/E/G ratio of 1.09 and a beta of 0.81. The company’s fifty day simple moving average is $74.23 and its 200 day simple moving average is $64.52. Unum Group has a 12-month low of $46.39 and a 12-month high of $77.69.

Unum Group (NYSE:UNM) last released its quarterly earnings data on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.10 by $0.03. Unum Group had a net margin of 13.76% and a return on equity of 15.21%. The company had revenue of $3.22 billion for the quarter, compared to analysts’ expectations of $3.26 billion. During the same quarter in the prior year, the firm earned $1.94 EPS. The business’s revenue was up 4.0% on a year-over-year basis. As a group, sell-side analysts forecast that Unum Group will post 8.54 earnings per share for the current fiscal year.

Unum Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be issued a $0.42 dividend. The ex-dividend date is Friday, January 24th. This represents a $1.68 annualized dividend and a yield of 2.20%. Unum Group’s payout ratio is currently 18.18%.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.